Accepting the caveats concerning possible confounding influence from diet and cell death [1] , the measurement of in urine is thought to provide a non-invasive assessment of whole body oxidative stress. This represents a number of advantages over other possible biomarkers of oxidative stress. The non-invasive nature of the assay make it less of an ethical issue than, for example, bloodbased assessments of oxidative stress, in particular when sampling from vulnerable groups is required. Many of the issues of adventitious damage, associated with the study of cellular 8-oxodG [2] , are circumvented by analysis of urine. Urine is easily collected and transported.
liquid chromatography pre-purification prior to GC-MS, HPLC-GC/MS, HPLC-EC, GC-MS [5] ). However, a significant number of reports in the literature use competitive enzymelinked immunosorbant assay (ELISA), and in particular the commercially available kit from the Japanese Institute for the Control of Aging (JaICA), although use of 'custom made' ELISAs has also been reported [6] [7] [8] . The benefits of ELISA are (i) ease of use; (ii) no specialist (or indeed expensive) equipment is required; (iii) potential application to numerous extracellular matrices (serum [9] , plasma [10] , saliva [11, 12] , urine [13] , CSF [14, 15] , cell culture medium [16] [17] [18] and sputum [19] , in contrast to the, to date, rather limited repertoire of matrices analysed by chromatographic techniques, with the exception of that reported by Bogdanov et al. [20] ; (iv) other than centrifugation of cloudy specimens, no pre-treatment of urine is required (v) high throughput.
However, there exists major criticisms of ELISA concerning (i) lack of perfect correlation with established chromatographic techniques, and (ii) apparent over-estimation of background levels of urinary 8-oxodG in healthy individuals. Whilst correlations have been demonstrated between the ELISA and chromatographic techniques e.g. r = 0.46 [21] , r s = 0.56 [22] , (both) p< 0.001 vs. HPLC-ECD; and r= 0.73, p = 0.002 vs. HPLC-GC/MS [23] these have been far from 1:1 and statistical significance is not always achieved [24] .
Differences in mean urinary 8-oxodG levels can vary anywhere from four-to ten-fold between ELISA and chromatographic techniques. Overall, this does suggest that both techniques share a common analyte, with the ELISA perhaps recognising additional compounds, and as a consequence a number of groups have been actively trying to address this the issue of discrepancy. For example, improvements by the manufacturer of the JaICA kit (narrowing calibration curve range; recommendation for strict temperature control), have reduced the margin in background levels between the two approaches. More recently, further improvements have been noted, following overnight incubation of the primary antibody at 4 ºC [25] .
Data concerning the antigens recognised by the primary antibody of the JaICA kit (denoted N45.1) suggest the antibody to be highly specific for 8-oxodG [26] . This, in part, derives from recognition of the hydroxylated C8 position of Gua, it would appear to discriminate the C6 carbonyl group of 8-oxoGua (and C2 NH 2 ), from the C6 amino group of 8-oxoAde. Furthermore, the closest competitors, other than 8-oxodG, for the antibody is 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxodGMP [25] , the former of which needs to be present in concentrations two orders of magnitude higher than 8-oxodG, in order to compete to the same extent [26] , a situation that does not appear to occur in vivo [27] . It is unknown whether 8-oxodGMP is present in urine. Toyokuni et al. [26] also reported that other endogenous constituents, present at high concentrations, in urine, such as uric acid, urea and creatinine, show no cross-reactivity with the antibody.
In this issue of Free Radical Biology and Medicine, Song et al. [28] demonstrate that urea is, in fact, one of the major contributors to the over-estimation of urinary 8-oxodG by ELISA. The authors' approach to better understand the reactivity of N45.1 is to fractionate a human urine sample, and to test aliquots of these fractions for reactivity in the ELISA. The first eluting ELISA-positive fractions was, using retention time as a guide, surmised to contain urea and allantoin, the second fraction contained 8-oxodG. Both urea and allantoin were then screened in the ELISA, with urea demonstrating competition with 8-oxodG for antibody binding. This raises the question 'why this was not noted during antibody characterisation?'. In the work of Song et al. [28] , a urea concentration of 10-80 mg/mL was used, levels similar to that seen in human urine. In contrast, the concentrations used during the characterisation of N45.1 were four orders of magnitude lower than that present in human urine, explaining the apparent lack of reactivity [26] . This raises the possibility that urease treatment of urine, prior to ELISA may bring the results into closer agreement with a chromatographic approach. Indeed, this does appear to be the case. The authors also exploited a recent development in which performing the JaICA ELISA kit's primary antibody step at 4 ºC, rather than 37 ºC, improved the agreement between ELISA and LC-MS/MS [25] . This further decreased the recognition of urea by N45.1, and demonstrated the most significant correlation with HPLC-EC, to date (r = 0.98; p < 0.0001). The authors conclude that other, as yet unidentified, cross-reacting substances may be present in urine, which account for the remaining disagreement with chromatographic techniques. They also note that, in their study, only a 7-fold greater concentration of 8-oxoGuo is required to compete for 8-oxodG, unlike the previous reports of one or two orders of magnitude [25, 26] .
Identifying the basis of the discrepancy between ELISA and chromatographic assays has proven to be problematic, but some progress has been made [25] . The report of Song et al. [28] has further added to our understanding of the discrepancy between ELISA and chromatographic method, and hence indicated possible ways to further improve the ELISA. Nevertheless, there still remains a discrepancy, even with urease pre-treatment, or low temperature incubation of the primary antibody. Further work is clearly required, not least to further validate the use of these methodological improvements, before ELISA can be recommended, without comparison with established chromatographic methods, for the specific measurement of urinary 8-oxodG.
